CAS RN: 145040-37-5
Candesartan Cilexetil
Product Availability
Choose a grade to view its available package options.
13 package records11 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
|---|---|---|---|---|
| Batchno.20250626 | 100g | In stock | Shanghai, Shenzhen, Tianjin | Inquiry |
| Batchno.20260614 | 10g | In stock | Shanghai, Tianjin | Inquiry |
| Batchno.20251120 | 10mg | In stock | Shanghai, Wuhan | Inquiry |
| Batchno.20250207 | 1g | In stock | Shanghai | Inquiry |
| Batchno.20251202 | 1mg | In stock | Shanghai, Wuhan | Inquiry |
| Batchno.20250917 | 25g | In stock | Shanghai, Tianjin | Inquiry |
| Batchno.20250615 | 50mg | In stock | Shanghai, Wuhan | Inquiry |
| Batchno.20260203 | 5g | In stock | Shanghai, Shenzhen, Tianjin, Wuhan, Chengdu | Inquiry |
- Product code: SSC-056412
Historical Factory Record
Historical Supply Reference
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
- Pack sizes on record: 25g
- Available purity: ≥95%
- Inventory rows with stock: 0
- Bulk packaging: confirmed by inquiry
Reference Pack Sizes
Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.
| Pack Size | Recorded Purity | Available Qty | Ship From | Inquiry |
|---|---|---|---|---|
| 25g | ≥95% | 0 Out of Stock | Shenzhen | Inquiry |
145040-37-5 / 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
Basic Information
CAS
145040-37-5
Multi CAS
No
Molecular Formula
C33H34N6O6
Molecular Weight
610.700000
Exact Mass
610.253983
SMILES
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6
InChI
InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)
InChIKey
GHOSNRCGJFBJIB-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
45
Aromatic heavy atom count
26
Fraction Csp3
0.33
Rotatable bonds
10
H-bond acceptors
11
H-bond donors
1
Molar refractivity
164.37
TPSA
143.34
LogP / Solubility
WLOGP
6.32
MLOGP
5.61
XLogP3
7
Consensus LogP
6.31
Log S (ESOL)
-7.37
Class (ESOL)
Insoluble
Log S (Ali)
-9.13
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.07
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.96
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
6
Safety & Transport
Pictogram(s)
Irritant
Health Hazard
Environmental Hazard
Signal
Danger
GHS Hazard Statements
H302 (26.9%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (26.4%): Harmful in contact with skin [Warning Acute toxicity, dermal]
H315 (26.4%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (26.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H332 (26.4%): Harmful if inhaled [Warning Acute toxicity, inhalation]
Precautionary Statement Codes
P203, P260, P261, P263, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501
